| Primary |
| Pulmonary Hypertension |
53.2% |
| Pulmonary Arterial Hypertension |
23.8% |
| Hypertension |
4.6% |
| Cardiac Disorder |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Scleroderma |
1.3% |
| Diabetes Mellitus |
1.3% |
| Lung Disorder |
1.2% |
| Dyspnoea |
1.0% |
| Pain |
1.0% |
| Atrial Fibrillation |
1.0% |
| Cor Pulmonale Chronic |
0.9% |
| Anticoagulant Therapy |
0.9% |
| Primary Pulmonary Hypertension |
0.8% |
| Blood Pressure Abnormal |
0.7% |
| Cardiac Failure |
0.7% |
| Depression |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Pulmonary Fibrosis |
0.7% |
| Thyroid Disorder |
0.7% |
|
| Death |
55.6% |
| Pulmonary Hypertension |
11.5% |
| Pneumonia |
3.2% |
| Dyspnoea |
3.0% |
| Off Label Use |
2.5% |
| Cardiac Failure |
2.4% |
| Renal Failure |
2.1% |
| Respiratory Failure |
2.0% |
| Disease Progression |
1.9% |
| Cardiac Failure Congestive |
1.8% |
| Right Ventricular Failure |
1.7% |
| Hypotension |
1.7% |
| Malaise |
1.7% |
| Myocardial Infarction |
1.6% |
| Headache |
1.6% |
| Cardiac Disorder |
1.2% |
| Lung Disorder |
1.2% |
| Visual Acuity Reduced |
1.2% |
| Weight Decreased |
1.1% |
| Fall |
1.0% |
|
| Secondary |
| Pulmonary Hypertension |
28.1% |
| Pulmonary Arterial Hypertension |
21.7% |
| Hypertension |
5.5% |
| Product Used For Unknown Indication |
5.3% |
| Cardiac Failure |
3.8% |
| Scleroderma |
3.7% |
| Drug Use For Unknown Indication |
3.2% |
| Sedation |
3.2% |
| Cardiac Disorder |
2.9% |
| Depression |
2.7% |
| Resuscitation |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Hiv Infection |
2.1% |
| Atrial Fibrillation |
2.0% |
| Thrombosis |
2.0% |
| Lung Disorder |
2.0% |
| Anticoagulant Therapy |
1.9% |
| Pain |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Sepsis |
1.6% |
|
| Death |
14.7% |
| Pulmonary Hypertension |
12.0% |
| Off Label Use |
8.6% |
| Multi-organ Failure |
7.4% |
| Hypotension |
5.5% |
| Pneumonia |
5.5% |
| Dyspnoea |
4.9% |
| Right Ventricular Failure |
4.6% |
| Oedema Peripheral |
3.4% |
| Palpitations |
3.4% |
| Pulmonary Arterial Hypertension |
3.4% |
| Vomiting |
3.4% |
| Drug Ineffective |
3.1% |
| Paraesthesia |
3.1% |
| Rash |
3.1% |
| Weight Decreased |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Urticaria |
2.8% |
| Visual Acuity Reduced |
2.8% |
| Dizziness |
2.5% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
64.3% |
| Pulmonary Hypertension |
12.0% |
| Product Used For Unknown Indication |
10.1% |
| Cor Pulmonale Chronic |
3.1% |
| Drug Use For Unknown Indication |
1.4% |
| Hypertension |
1.2% |
| Scleroderma |
0.7% |
| Essential Hypertension |
0.7% |
| Cardiac Failure |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Oedema |
0.6% |
| Pain |
0.6% |
| Prophylaxis |
0.6% |
| Asthma |
0.5% |
| Cardiac Failure Congestive |
0.5% |
| Depression |
0.5% |
| Rheumatoid Arthritis |
0.5% |
| Atrial Fibrillation |
0.5% |
| Supplementation Therapy |
0.5% |
|
| Death |
30.5% |
| Dyspnoea |
8.7% |
| Pneumonia |
8.6% |
| Pulmonary Arterial Hypertension |
5.0% |
| Syncope |
4.7% |
| Oedema Peripheral |
4.4% |
| Pulmonary Hypertension |
3.8% |
| Respiratory Failure |
3.8% |
| Fluid Retention |
3.5% |
| Oedema |
3.3% |
| Vomiting |
3.2% |
| Right Ventricular Failure |
3.1% |
| Weight Increased |
2.7% |
| Renal Failure |
2.2% |
| Cardiac Failure Congestive |
2.2% |
| Nasal Congestion |
2.2% |
| Liver Function Test Abnormal |
2.1% |
| Anaemia |
2.1% |
| Unevaluable Event |
2.0% |
| Pulmonary Oedema |
1.9% |
|
| Interacting |
| Hypertension |
14.8% |
| Pulmonary Hypertension |
9.3% |
| Anticoagulant Therapy |
8.8% |
| Dyspnoea |
8.8% |
| Pulmonary Arterial Hypertension |
8.8% |
| Cardiac Disorder |
4.4% |
| Gait Disturbance |
4.4% |
| Lung Disorder |
4.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.4% |
| Pulmonary Embolism |
4.4% |
| Hypertensive Heart Disease |
3.3% |
| Maintenance Of Anaesthesia |
3.3% |
| Renal Failure Chronic |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Endotracheal Intubation |
2.7% |
| Pain |
2.7% |
| Angina Pectoris |
2.2% |
| Induction Of Anaesthesia |
2.2% |
| Osteoarthritis |
2.2% |
| Right Ventricular Failure |
2.2% |
|
| Dyspnoea |
11.8% |
| Extrasystoles |
11.8% |
| Gingival Bleeding |
8.8% |
| Pulmonary Hypertension |
8.8% |
| Rhinorrhoea |
8.8% |
| Tracheal Haemorrhage |
8.8% |
| Anaemia |
5.9% |
| Drug Interaction |
5.9% |
| Hypotension |
5.9% |
| Tumour Haemorrhage |
5.9% |
| Hepatocellular Injury |
2.9% |
| Hyperhidrosis |
2.9% |
| Obstructive Airways Disorder |
2.9% |
| Right Ventricular Failure |
2.9% |
| Tinnitus |
2.9% |
| Vision Blurred |
2.9% |
|
